Identification of MYLK3 mutations in familial dilated cardiomyopathy
暂无分享,去创建一个
H. Aburatani | N. Hagiwara | I. Komuro | S. Nomura | H. Morita | T. Fujita | T. Ko | Takashige Tobita | H. Toko | K. Uto | Seitaro Nomura
[1] L. Calò,et al. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.
[2] X. Puente,et al. Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C , 2016, European Journal of Human Genetics.
[3] Gaelen T. Hess,et al. Translation readthrough mitigation , 2016, Nature.
[4] Tsippi Iny Stein,et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.
[5] J. Eppig,et al. Inferring gene-to-phenotype and gene-to-disease relationships at Mouse Genome Informatics: challenges and solutions , 2016, J. Biomed. Semant..
[6] K. Okamura,et al. Human genetic variation database, a reference database of genetic variations in the Japanese population , 2016, Journal of Human Genetics.
[7] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[8] Y. Gondo,et al. Degradation of Stop Codon Read-through Mutant Proteins via the Ubiquitin-Proteasome System Causes Hereditary Disorders* , 2015, The Journal of Biological Chemistry.
[9] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[10] Kengo Kinoshita,et al. Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals , 2015, Nature Communications.
[11] D. G. MacArthur,et al. Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.
[12] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[13] T. Burghardt,et al. Ventricular myosin modifies in vitro step-size when phosphorylated. , 2014, Journal of molecular and cellular cardiology.
[14] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[15] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[16] K. Boycott,et al. Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.
[17] Heng Li. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.
[18] P. Robinson,et al. Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy , 2013, European Journal of Human Genetics.
[19] E. McNally,et al. Genetic mutations and mechanisms in dilated cardiomyopathy. , 2013, The Journal of clinical investigation.
[20] M. Swanson,et al. Myosin Light Chain Phosphorylation Is Critical for Adaptation to Cardiac Stress , 2012, Circulation.
[21] Barry J Maron,et al. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. , 2012, Journal of the American College of Cardiology.
[22] T. Inada,et al. Dom34:hbs1 plays a general role in quality-control systems by dissociation of a stalled ribosome at the 3' end of aberrant mRNA. , 2012, Molecular cell.
[23] R. Hershberger,et al. Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. , 2011, Journal of the American College of Cardiology.
[24] Marco Merlo,et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. , 2011, Journal of the American College of Cardiology.
[25] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[26] J. Stull,et al. Cardiac Myosin Light Chain Kinase Is Necessary for Myosin Regulatory Light Chain Phosphorylation and Cardiac Performance in Vivo* , 2010, The Journal of Biological Chemistry.
[27] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[28] N. Sato,et al. Identification of Cardiac-Specific Myosin Light Chain Kinase , 2008, Circulation research.
[29] K. Kawakami,et al. A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. , 2007, The Journal of clinical investigation.
[30] E. Kinoshita,et al. Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins*S , 2006, Molecular & Cellular Proteomics.
[31] R. Hershberger,et al. Clinical and genetic issues in familial dilated cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[32] Roy Parker,et al. Exosome-Mediated Recognition and Degradation of mRNAs Lacking a Termination Codon , 2002, Science.
[33] H. Wen,et al. The Overall Pattern of Cardiac Contraction Depends on a Spatial Gradient of Myosin Regulatory Light Chain Phosphorylation , 2001, Cell.
[34] R. Hershberger,et al. Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice. , 1999, Journal of the American College of Cardiology.
[35] J. Stull,et al. Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. , 1993, The American journal of physiology.
[36] J. Clegg,et al. Haemoglobin Constant Spring—A Chain Termination Mutant ? , 1971, Nature.
[37] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[38] Kenneth A Ellenbogen,et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.
[39] Z. Papp,et al. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. , 2003, Cardiovascular research.
[40] J. Nietupski,et al. CHALLENGES AND SOLUTIONS , 2001 .
[41] K. Kinzler,et al. A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.